Page 2 - Pharmaceutical Compounding News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A beta blocker eye drop that costs less than $10 may be able to help acute migraine sufferers ...

Russell Investments Group Ltd. bought a new stake in Harrow Health, Inc. (NASDAQ:HROW – Get Rating) during the 4th quarter, Holdings Channel reports. The fund bought 285,436 shares of the company’s stock, valued at approximately $2,464,000. Other hedge funds and other institutional investors have also modified their holdings of the company. Opaleye Management Inc. boosted […]

Harrow Health (NASDAQ:HROW – Get Rating) issued its quarterly earnings data on Thursday. The company reported ($0.27) EPS for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.35), MarketWatch Earnings reports. Harrow Health had a negative net margin of 14.11% and a positive return on equity of 13.06%. During the same period last year, […]

Hamad Medical Corporation (HMC) s National Centre for Cancer Care and Research (NCCCR) is planning to introduce a range of innovative services to trea...

The Ohio Northern University Raabe College of Pharmacy student will share his vision of “The Compounding Pharmacy of the Future” at the compounding...